Edifecs to Speak on the Power of Artificial Intelligence at 2023 WEDI National Conference
Learn how AI unlocks a new level of value-based care and clinical decisions supportBELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health...
Medicaid
Therma Bright Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States
Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the...
Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc., (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation activation company focused on the discovery,...
Panoramic Health Appoints Dr. Tarek Elsawy as New CEO
TEMPE, AZ / ACCESSWIRE / October 3, 2023 / Panoramic Health has appointed Dr. Tarek Elsawy as Chief Executive Officer...
America’s Hidden Diabetes Epidemic: The Devastating Link Between Missing Teeth and Disease
How clinics like Dr. Alex Einbinder's Grace Dental Smiles can help stop the vicious cycleWEST BABYLON, NY / ACCESSWIRE /...
BioStem Technologies: CMS Decision a “Win For Patients”
POMPANO BEACH, FL / ACCESSWIRE / September 29, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company...
Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review
If approved, odronextamab would be the first and only bispecific antibody approved in both FL and DLBCL – the two...
Renalytix Reports Full Year Fiscal 2023 Results
LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
-- UPC numbers assigned by Wolters Kluwer Health, provider of trusted clinical technology ---- PoNS system and mouthpiece will be...
Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023
PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states
SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states Medunik USA (member of Duchesnay Pharmaceutical Group) is...
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference
Company’s First-Ever ANPT Booth Sponsorship Enables Specialists to Learn More about this Breakthrough Technology on Eve of National Physical Therapy...
New Research From Inovalon and Harvard Uncovers Utilization and Cost Differences Between Medicare Advantage and Traditional Medicare
Data Shows Medicare Advantage is Substantially Reducing Costs and Hospitalizations Without Sacrificing Access to Care Relative to Traditional Fee-for-Service MedicareBOWIE,...
Equip Welcomes Adults with Expansion of Virtual Evidence-Based Eating Disorder Treatment
Following years of growth and industry-changing outcomes, the leader in eating disorder treatment announces awaited program extensionSAN DIEGO, Sept. 19,...
Icario to Showcase Digital-First Healthcare Innovation at Three Key Industry Events in October
Health Action Leader to Have a Presence at HLTH 2023, MHPA23 and the NCQA Health Innovation SummitMINNEAPOLIS, Sept. 19, 2023...
NCQA Unveils 2023 Health Plan Ratings
Successful Reporting of New Direct Race and Ethnicity Measure by 92% of Plans Bodes Well for Improving Health EquityWASHINGTON, DC...
Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
Interventional study compares VitaGraft to current transplant rejection monitoring protocolsOncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than...
Kalderos Adds Powerful Features to Commercial Drug Discount Monitoring Solution
Drug Discount Management Leader Delivers New Tools to Tackle Billions in Overpaid Commercial Rebates CHICAGO, Sept. 14, 2023 /PRNewswire/ --...
MSSP ACOs on the Innovaccer Platform Generated 47.5% Greater Savings, $370 Million Cumulative in PY 2022
Seventh consecutive year that Innovaccer's customers excelled as high-performing ACOs SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ -- Today, Innovaccer, the healthcare...
Sequana Medical announces H1 2023 results and provides business update
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION14 September 2023, 07:00 CEST alfapump® – strong pivotal POSEIDON data presented at leading international...